SEC Form D · filed February 10, 2023
Allyx Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Stephen Bloch · New Haven, CTExec · DirectorTimothy P. Siegert · Hamden, CTExecStephen Strittmatter · Durham, CTDirectorGregory P. Ho · New York, NYDirectorRobert A. Bettigole · New Haven, CTDirectorPaul P. Fonteyne · Westport, CTDirectorHerbert Frazier · Boston, MAExecLeon N. Bressler · London, United KingdomDirectorDaniel Conant · Shepherdstown, WVDirectorAner Ben-Ami · Shepherdstown, WVExec · DirectorKiran Bhatraju · Shepherdstown, WVDirectorSteve Sershen · Chester, SDDirectorW. C. Bade · Ann Arbor, MIDirectorYihe Zhang · Hoboken, NJDirectorDonald R. Carter · Rancho Santa Fe, CADirectorAdrian Martin-Jimenez · Grand Cayman, Cayman IslandsExec · DirectorPablo Defelippe · Luxembourg, LuxembourgExecEdward Patton · Concord, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗